Dunav Re a.d (XBEL:DNREM) YoY EBITDA Growth: -9.88% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBEL:DNREM Dunav Re a.d XBEL:DNREM
81 GF Score
Price RSD6,101.00
GF Value RSD5,242.78
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Dunav Re a.d YoY EBITDA Growth?

Dunav Re a.d XBEL:DNREM -19.71% 81 YoY EBITDA Growth is -9.88% as of Dec. 2025. GuruFocus rates XBEL:DNREM with a GF Score™ of 81/100 and a GF Value™ of RSD5,242.78 (Modestly Overvalued). The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dunav Re a.d's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was -9.88%.

Dunav Re a.d's EBITDA per Share for the six months ended in Dec. 2025 was RSD348.90.

Dunav Re a.d YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Dunav Re a.d's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dunav Re a.d YoY EBITDA Growth Chart

Dunav Re a.d Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -91.10 40.71 75.23 2.98 9.08

Dunav Re a.d Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.17 84.01 -44.12 18.99 -9.88
XBEL:DNREM
81GF Score
Dunav Re a.d XBEL:DNREM
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dunav Re a.d YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dunav Re a.d's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(1230.752-1128.262)/ | 1128.262 |
=9.08 %

Dunav Re a.d's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(348.897-387.15)/ | 387.15 |
=-9.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -9.88% mean?
Dunav Re a.d (XBEL:DNREM) has a YoY EBITDA Growth of -9.88% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dunav Re a.d and its competitors.
Is Dunav Re a.d's YoY EBITDA Growth too high?
Dunav Re a.d's current YoY EBITDA Growth is -9.88%. Overall, Dunav Re a.d has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dunav Re a.d's YoY EBITDA Growth compare to RGA and EG?
Dunav Re a.d's YoY EBITDA Growth of -9.88% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dunav Re a.d and its competitors. Dunav Re a.d's current YoY EBITDA Growth is -9.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dunav Re a.d stock overvalued right now?
Based on GuruFocus' analysis, Dunav Re a.d (XBEL:DNREM) is currently considered Modestly Overvalued. The stock's GF Value™ is RSD5,242.78, compared to a current price of RSD6,101.00 — trading 16.4% above its estimated fair value. The current YoY EBITDA Growth is -9.88%. Dunav Re a.d's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Dunav Re a.d (XBEL:DNREM), the current YoY EBITDA Growth is -9.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dunav Re a.d (XBEL:DNREM) Overvalued in 2026?

Based on GuruFocus' analysis, Dunav Re a.d stock appears to be overvalued. The current stock price of RSD6,101.00 is trading 16.4% above its estimated GF Value™ of RSD5,242.78. GuruFocus considers Dunav Re a.d to be Modestly Overvalued.

Key valuation signals for XBEL:DNREM:

  • YoY EBITDA Growth: -9.88%
  • GF Value™: RSD5,242.78 vs. price of RSD6,101.00 (16.4% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the XBEL:DNREM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dunav Re a.d Business Description

Address Bulevar kralja Aleksandra 18, 1st floor, Beograd, SRB, 11000
Dunav Re a.d is a joint-stock reinsurance company. It provides reinsurance protection. It operates in countries such as Slovenia, Croatia, Bosnia and Herzegovina, Montenegro, Albania, Turkish part of Cyprus, Germany, Russia, Bulgaria, North Africa (Morocco, Algeria), Asia-Emirates.
81GF Score

Get the complete analysis for XBEL:DNREM

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RSD6,101.00
Price
RSD5,242.78
GF Value